SCHEMBL753830

SCHEMBL753830

O=S(=O)(Cc1ccc(Cl)cc1Cl)C(Br)Br

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 4/20 0.46
ERCC1 P07992 1/20 0.44
ERCC4 Q92889 1/20 0.44
CYP1A2 P05177 2/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2C19 P33261 2/20 0.44
CYP2C9 P11712 1/20 0.44
MAPK1 P28482 1/20 0.44
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
GGPS1 O95749 1/20 0.40
NPC1 O15118 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
CYP2D6 P10635 1/20 0.38
ALOX15 P16050 1/20 0.38
EPHX1 P07099 1/20 0.37
HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1625791 0.79 IDO1 (0.54) IDO1ERCC1ERCC4CYP1A2CYP3A4
SCHEMBL754045 0.78 ALDH1A1 (0.49) IDO1KMT2ANPC1ALDH1A1MAPT
SCHEMBL271766 0.77 IDO1 (0.52) IDO1ERCC1ERCC4CYP1A2CYP3A4
SCHEMBL3324634 0.76 ERCC1 (0.51) IDO1ERCC1ERCC4CYP1A2CYP3A4
SCHEMBL5615558 0.76 IDO1 (0.50) IDO1ERCC1ERCC4CYP1A2CYP3A4
SCHEMBL3672833 0.76 ERCC1 (0.51) IDO1ERCC1ERCC4CYP1A2CYP3A4
SCHEMBL6011808 0.76 IDO1 (0.50) IDO1ERCC1ERCC4CYP1A2CYP3A4
SCHEMBL5615559 0.74 ERCC1 (0.50) IDO1ERCC1ERCC4CYP1A2CYP3A4
SCHEMBL752569 0.71 PNMT (0.50) IDO1CYP3A4KMT2AMEN1ALDH1A1
SCHEMBL16914886 0.71 ERCC1 (0.58) IDO1ERCC1ERCC4CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2213166-B1 Biocidal compounds containing 2-methylisothiazolin-3-one and a haloalkylsulfone THOR GMBH (DE) 2012-03-21 EP claimed
US-20100189811-A1 Biocide compositions comprising 3-methylisothiazolin-3-one and a haloalkyl sulphone THOR GMBH (DE) 2010-07-29 US claimed
US-8287631-B2 Compounds for preventing ghost odour THOR GMBH (DE) 2012-10-16 US disclosed
US-20100189811-A1 Biocide compositions comprising 3-methylisothiazolin-3-one and a haloalkyl sulphone THOR GMBH (DE) 2010-07-29 US disclosed
US-20100186631-A1 Compounds for preventing ghost odour THOR GMBH (DE) 2010-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100189811-A1 Biocide compositions comprising 3-methylisothiazolin-3-one and a haloalkyl sulphone MBTD1, MPST, B2M IDO1 310/4885ERCC1 314/4885ERCC4 473/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.